Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
More information is needed to be able to interpret study's results
| The first 150 words of the full text of this article appear below. |
EDITOR
Nielsen et al found that the use of non-steroidal
anti-inflammatory drugs in early pregnancy was associated with an increased risk of miscarriage but not with congenital abnormality, low
birth weight, or preterm delivery.1 Unfortunately, the study has several deficiencies that make interpretation of the results difficult.
Firstly, the study was based on the Danish birth registry and the prescription database; the clinical information available was limited, and a random sample confirmed the prescription in only 71% of the pregnancies. Although the authors state that the data had high validity, Kristensen et al reported that the birth registry under-reported the incidence of preterm delivery by over 50%.2
Secondly, in assessing the risk of miscarriage the authors
stratified the study group according to the time between the
prescription of non-steroidal anti-inflammatory drugs and the date of
discharge from hospital after miscarriage. How the control group was
stratified is not clear.